entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 20:59:55 - browse：3231

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Readout Newsletter: Bluebird, CVS, Contineum

knowledge

WSS

FDA approves updated Covid vaccines

Positive childhood experiences can help future health

Neuroscience’s long legacy of racism

Long Covid needs a new name — and a new frame

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Positive childhood experiences can help future health

leisure time

entertainment

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

FDA proposes changes to key medical devices approval pathway

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Telehealth for opioid use disorder is lifesaving

Anesthesiologist group: stop taking Ozempic before surgery

Food makers tried to stack nutrition panel with preferred experts

Psychedelics group wrestles with new pharma identity

Pig kidney works a record two months in donated body

What does generative AI mean for health care? We asked experts

Readout Newsletter: Bluebird, CVS, Contineum

explore

Baby aspirin cuts fat buildup in liver disease patients, in small study

Health AI adoption puts security, privacy startups on investors' radar

How to make the FDA’s new prescription one

FDA panel endorses Alnylam’s heart drug — after picking it apart

Generate Biomedicines machine learning biotech raises $273M

Acelyrin, a rare IPO success, stumbles in its first big test

knowledge

knowledge

explore

Wikipedia